AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹996 Cr | ₹895 Cr | ₹1,139 Cr | ₹647 Cr | ₹839 Cr |
What is the latest Total Current Liabilities ratio of AJANTA PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹996 Cr |
| Mar2024 | ₹895 Cr |
| Mar2023 | ₹1,139 Cr |
| Mar2022 | ₹647 Cr |
| Mar2021 | ₹839 Cr |
How is Total Current Liabilities of AJANTA PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹996 Cr | 11.27 | |
| Mar2024 | ₹895 Cr | -21.42 | |
| Mar2023 | ₹1,139 Cr | 75.98 | |
| Mar2022 | ₹647 Cr | -22.82 | |
| Mar2021 | ₹839 Cr | - | |
Compare Total Current Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹30,726.0 Cr | -4.2% | -0.6% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,211.0 Cr | 1.6% | 6% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,898.0 Cr | -0.7% | -1.9% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,377.0 Cr | -0.8% | 7.4% | 21.2% | Stock Analytics | |
| CIPLA | ₹122,349.0 Cr | -0.4% | -3.4% | 0.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,789.0 Cr | 1.2% | 0.3% | -1.5% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -4.2% |
-0.6% |
-11.9% |
| SENSEX | 1% |
2.5% |
6.5% |
You may also like the below Video Courses